Funding Details
- Awarder
- Inbox
- Date Award
- September 28, 2018
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
-
$80,000,000
Company Info
- Founders
- David Meeker
- Company Description
- KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.
- Market
- Pharmaceuticals
- Location
-
Cambridge,
Massachusetts,
USA
- Coinvestors
- Alexandria Real Estate Equities, ARCH Venture Partners, Baillie Gifford, Cowen Healthcare Investments, Flagship Pioneering, Invus, Lilly Asia Ventures, Polaris Partners
Links